Rheinmetall's December Reckoning: Boxer Decision Looms as Order Book Keeps Swelling
Published on 08/18/2026 at 17:21 | Redaktion boerse-global.de
The defense contractor's calendar is stacking up. A Bundestag verdict on the "Arminius" wheeled armored vehicle program is expected in the first or second week of December, a decision that could unlock one of the largest procurement efforts in recent German military history. Up to 3,000 Boxer vehicles are on the table under the consortium framework with KNDS, and CEO Armin Papperger has signaled confidence, telling reporters that "nothing" stands in the way of the project.
That optimism sits alongside a steady drumbeat of smaller but meaningful contract wins. Rheinmetall recently booked a Bundeswehr order for mobile field hospitals valued at over EUR 500 million, with an option that could push the gross total past EUR 600 million. Production is slated to begin in the first quarter of 2027. The award, logged in July, joins an order backlog that has swelled beyond EUR 80 billion, buttressed by a loitering munitions contract and a EUR 11.371 billion SAFE package with Romania.
The medical-station deal is part of a broader diversification push that extends well beyond traditional weapons systems. Rheinmetall has also delivered 56 additional Elefant 2 heavy transporters to the Bundeswehr, worth roughly EUR 60.5 million gross, expanding a framework agreement originally covering up to 137 vehicles. Together, the contracts illustrate a portfolio that now spans logistics, medical infrastructure, and heavy equipment — a deliberate strategy to embed the company deeper into the Bundeswehr's rearmament agenda.
Large-scale operations like these bring complex risk management challenges — and the same is true in any workplace. Many employers underestimate the gaps in their safety documentation until an incident occurs. A free Risk Assessment Toolkit with 41 ready-to-use templates and checklists helps you document hazards properly and stay compliant. Download the free Risk Assessment Toolkit
A Volatile Tape and a Divided Sell-Side
The share price tells a more complicated story. After what management called the best quarter in the company's 137-year history, the stock still tumbled 8.5 percent on the day of the earnings release last Thursday. It has since recovered, trading at EUR 1,214.00 — up 6.3 percent on the week and 23 percent on the month. Yet the equity remains 40 percent below its October 3 high of EUR 2,007.00, and it is down 22 percent year-to-date.
That wide trading range reflects a fractured analyst community. Goldman Sachs maintains a "Buy" rating with a EUR 2,300 price target, while mwb research downgraded the stock from "Hold" to "Sell" last Friday, slashing its target to EUR 1,050 on concerns about a less favorable risk-reward profile, a halved investment ratio, and a reduced backlog target. The broader consensus across 20 houses remains more constructive, with an average price target between EUR 1,679 and EUR 1,700 and 17 buy recommendations.
The F126 Setback and a CEO's Vote of Confidence
The recent turbulence follows the abrupt halt of the F126 frigate program in July, a project that had been expected to contribute meaningfully to future revenue. Papperger responded by purchasing roughly EUR 3 million worth of Rheinmetall shares through his investment vehicle ATP Holding GmbH — a move widely read as a signal of conviction in the company's long-term trajectory.
Rockets, Trucks, and an Open Question in Italy
Beyond the Boxer decision, Rheinmetall is advancing a joint ATACMS missile production facility with Lockheed Martin at its Unterlüß site in northern Germany. A letter of intent was signed in July, with production build-out scheduled to begin in 2027 and initial revenue expected in 2028. Papperger has cautioned, however, that the facility will not reach full capacity within two years — a reminder that the company's pattern of ambitious announcements often carries a delayed revenue impact.
The Iveco military vehicle business remains another open item. Talks with Leonardo are ongoing, though progress now depends on the incoming Leonardo CEO, Lorenzo Mariani. A "handshake agreement" had been reached with his predecessor, and Papperger insists the deal is not in jeopardy — but no contractual certainty exists yet.
Just as defense contractors must prove their systems meet rigorous standards, UK employers face their own compliance obligations. Over 37,000 British companies already use a free Health & Safety Toolkit covering key regulations like COSHH, PUWER and the Health & Safety at Work Act. It provides ready-to-use risk assessments and checklists you can deploy immediately. Get the free Health & Safety Toolkit
A December That Could Define the Next Phase
For investors, the near-term catalyst is clear: the Boxer decision. The program's scale — up to 3,000 vehicles — would dwarf recent contract wins and reinforce Rheinmetall's position as a cornerstone of European land defense. But the stock's valuation increasingly hinges on execution, not announcements. The gap between the October high and current levels suggests the market is demanding proof that the pipeline converts into earnings, not just order-book entries.
The field hospital contract and the Elefant 2 extension offer evidence of operational substance. The December verdict on Arminius will determine whether the market's skepticism or the analysts' optimism proves better calibrated.
